Abstract
It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Current Medicinal Chemistry
Title:A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging
Volume: 20 Issue: 1
Author(s): A.G. Khosroshahi, M. Amanlou, O. Sabzevari, F.J. Daha, M.R. Aghasadeghi, M. Ghorbani, M.S. Ardestani, M.S. Alavidjeh, S.M. Sadat, M.H. Pouriayevali, L. Mousavi and S.E.S. Ebrahimi
Affiliation:
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Abstract: It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Export Options
About this article
Cite this article as:
Khosroshahi A.G., Amanlou M., Sabzevari O., Daha F.J., Aghasadeghi M.R., Ghorbani M., Ardestani M.S., Alavidjeh M.S., Sadat S.M., Pouriayevali M.H., Mousavi L. and Ebrahimi S.E.S., A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging, Current Medicinal Chemistry 2013; 20 (1) . https://dx.doi.org/10.2174/0929867311302010012
DOI https://dx.doi.org/10.2174/0929867311302010012 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clonetics
Current Drug Metabolism The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Glioma Therapy: A Novel Insight in the Immunotherapeutic Regime with T11TS/SLFA-3
Central Nervous System Agents in Medicinal Chemistry [18F]Fluoroalkyl Agents: Synthesis, Reactivity and Application for Development of PET Ligands in Molecular Imaging
Current Topics in Medicinal Chemistry Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: PET/CT in External Beam Radiation Therapy Dose Planning)
Current Radiopharmaceuticals Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents
Anti-Cancer Agents in Medicinal Chemistry Application of Functional Genomics to Bronchial Asthma
Current Pharmacogenomics Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents
Current Topics in Medicinal Chemistry Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals
Current Drug Targets Meet Our Editorial Board Member
Letters in Drug Design & Discovery Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review
Current Medicinal Chemistry Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Compounds from Wild Mushrooms with Antitumor Potential
Anti-Cancer Agents in Medicinal Chemistry Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets Kisspeptin Mediated Signaling in Cancer
Current Topics in Medicinal Chemistry Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways
Anti-Cancer Agents in Medicinal Chemistry The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas
Current Cancer Drug Targets Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Biological Evaluation of Fluorinated p-Boronophenylalanine Derivatives as a Boron Carrier
Protein & Peptide Letters